• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
LIU Yefeng,LI Fei,XIE Wei,WANG Xing.Analysis on the expression and correlation of Cullin7 in gastric cancer[J].Journal Of Pharmaceutical Research,2024,43(4):327-332[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 2899times   Download 2987次 QR Code for this article
Scan with your phone!
Cullin7在胃癌中的表达及相关性分析
刘业锋1,李飞1,谢伟1,王星2
Font:Larger+|Default|Smaller-
(1.句容市人民医院普外科,江苏 句容 212400;2.中国药科大学药学院药理系,江苏 南京 211198)
摘要:
目的 探讨Cullin7在胃癌中的表达及其对胃癌发生发展的作用。方法 自癌症基因组图谱(TCGA)数据库下载胃癌患者mRNA水平数据,并进行生存状况分析;并收集了60例接受手术治疗胃癌患者的胃癌和癌旁组织样本,免疫组化分析Cullin7的表达水平,并评估Cullin7表达水平与胃癌患者临床病理特征之间的相关性;同时通过在人胃癌HGC-27细胞系中过表达或敲除Cullin7基因,利用四甲基偶氮唑盐(MTT)、集落形成、划痕、Transwell迁移和Matrigel侵袭实验研究Cullin7对胃癌细胞增殖、迁移和侵袭的影响。结果 Cullin7在胃癌组织中高表达,且Cullin7高表达的患者总生存期、首次进展和进展后生存时间更短,同时Cullin7的表达与胃癌患者分化程度、神经侵袭、血管侵袭、浸润深度、淋巴结转移、临床分期相关,差异有统计学意义,而Cullin7在胃癌细胞中的过表达促进细胞增殖、迁移和侵袭,而用短发夹RNA(shRNA)敲低Cullin7可以抑制胃癌细胞的增殖、迁移和侵袭,差异有统计学意义。结论 Cullin7的上调可能是促进胃癌发生和发展的重要因素,可作为胃癌诊断、预后新的生物标志物以及新的治疗靶点。
关键词:  胃癌  泛素连接酶CUL7蛋白抗体  预后  临床病理特征  增殖  迁移  侵袭
DOI:10.13506/j.cnki.jpr.2024.04.003
基金项目:江西省基础研究计划(自然科学基金)-青年基金项目(No.BK20180574)
Publication Date:April 25, 2024
Analysis on the expression and correlation of Cullin7 in gastric cancer
LIU Yefeng1,LI Fei1,XIE Wei1,WANG Xing2
(1.Department of General Surgery, The People's Hospital of Jurong, Jurong 212400,China; 2.Department of Pharmacology, School of Pharmacy, China Pharmaceutical University, Nanjing 211198,China)
Abstract:
Objective To investigate the expression of Cullin7 in gastric cancer and its role in the genesis and development of gastric cancer. Methods Download the mRNA level data of gastric cancer patients from The Cancer Genome Atlas (TCGA) database, and analyze the survival status; The expression level of Cullin 7 in gastric cancer and adjacent tissues of 60 patients with gastric cancer undergoing surgical treatment was analyzed by immunohistochemistry, and the correlation between the expression level of Cullin 7 and the clinicopathological characteristics of gastric cancer patients was evaluated. At the same time, through overexpression or knockout of Cullin7 gene in human gastric cancer HGC-27 cell line, the effects of Cullin7 on the proliferation, migration and invasion of gastric cancer cells were studied by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), colony formation, wound healing, Transwell migration and Matrigel invasion experiments.Results Cullin7 is highly expressed in gastric cancer, and patients with high expression of Cullin7 have shorter overall survival, and shorter first progression and post progression survival times. At the same time, the expression of Cullin7 is significantly related to the pathologic differentiation, nerve invasion, vascular invasion, depth of invasion, lymph node metastasis and clinical stage of gastric cancer patients. The ectopic expression of Cullin7 in gastric cancer cells significantly promotes cell proliferation, migration and invasion, while knocking down Cullin7 with short hairpin RNA (shRNA) can inhibit the proliferation, migration and invasion of gastric cancer cells. Conclusion Upregulation of Cullin7 may be an important factor promoting the occurrence and development of gastric cancer, and can be used as a new biomarker for gastric cancer diagnosis and prognosis as well as a new therapeutic target.
Key words:  Gastric cancer  Cullin7  Prognosis  Clinical pathology features  Proliferation  Migration  Invasion
Today's Visits:511    Total Visits:2383242
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.